Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Invesco Global Water ETF
PIO
$274M
| $13.8M | ﹤0.01% |
313,430
+9,791
| +3% | +$439K |
|
3277
Invesco Global Listed Private Equity ETF
PSP
$232M
| $13.8M | ﹤0.01% |
206,278
-83,027
| -29% | -$5.56M |
|
3278
Rocket Pharmaceuticals
RCKT
$343M
| $13.8M | ﹤0.01% |
3,941,377
+294,338
| +8% | +$1.01M |
|
3279
iShares Global Materials ETF
MXI
$340M
| $13.8M | ﹤0.01% |
143,089
-7,352
| -5% | -$682K |
|
3280
Cars.com
CARS
$705M
| $13.8M | ﹤0.01% |
1,132,889
-122,733
| -10% | -$1.43M |
|
|
VIA
3281
Via Transportation Inc
VIA
$1.67B
| $13.8M | ﹤0.01% |
475,695
+29,010
| +6% | +$1.2M |
|
3282
National Beverage
FIZZ
$3.05B
| $13.8M | ﹤0.01% |
432,692
+41,445
| +11% | +$1.42M |
|
3283
Mesa Laboratories
MLAB
$559M
| $13.8M | ﹤0.01% |
175,589
-79,385
| -31% | -$6.04M |
|
|
YSG
3284
Yatsen Holding
YSG
$322M
| $13.8M | ﹤0.01% |
3,541,612
+5,135
| +0.1% | +$32.6K |
|
3285
Marqeta
MQ
$1.9B
| $13.8M | ﹤0.01% |
724,923
-11,066
| -2% | -$213K |
|
3286
MoonLake Immunotherapeutics
MLTX
$1.59B
| $13.8M | ﹤0.01% |
1,044,581
+787,926
| +307% | +$9.3M |
|
3287
Ardelyx
ARDX
$1.25B
| $13.8M | ﹤0.01% |
2,358,806
-526,534
| -18% | -$2.93M |
|
|
AWP
3288
abrdn Global Premier Properties Fund
AWP
$379M
| $13.8M | ﹤0.01% |
1,193,629
+37,575
| +3% | +$439K |
|
3289
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$452M
| $13.7M | ﹤0.01% |
580,552
+380,864
| +191% | +$9.02M |
|
3290
Capitol Federal Financial
CFFN
$1.09B
| $13.7M | ﹤0.01% |
2,016,223
+272,780
| +16% | +$1.77M |
|
|
EXK
3291
Endeavour Silver
EXK
$2.29B
| $13.7M | ﹤0.01% |
1,457,902
+2,274
| +0.2% | +$19.3K |
|
3292
AtriCure
ATRC
$2.01B
| $13.7M | ﹤0.01% |
346,116
+157,300
| +83% | +$5.77M |
|
3293
Shutterstock
SSTK
$220M
| $13.7M | ﹤0.01% |
716,729
-108,062
| -13% | -$2.31M |
|
|
PDX
3294
PIMCO Dynamic Income Strategy Fund
PDX
$939M
| $13.7M | ﹤0.01% |
728,761
-6,553
| -0.9% | -$144K |
|
3295
iShares Interest Rate Hedged Long-Term Corporate Bond ETF
IGBH
$202M
| $13.7M | ﹤0.01% |
554,908
+82,110
| +17% | +$2.02M |
|
3296
The RMR Group
RMR
$343M
| $13.7M | ﹤0.01% |
916,830
+540,243
| +143% | +$8.22M |
|
3297
Quantum Computing Inc
QUBT
$1.74B
| $13.6M | ﹤0.01% |
1,329,581
-178,882
| -12% | -$2.55M |
|
3298
iShares MSCI Emerging Markets Asia ETF
EEMA
$816M
| $13.6M | ﹤0.01% |
144,936
+1,044
| +0.7% | +$97.6K |
|
3299
BioCryst Pharmaceuticals
BCRX
$2.48B
| $13.6M | ﹤0.01% |
1,745,563
-3,457,396
| -66% | -$25M |
|
3300
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$639M
| $13.6M | ﹤0.01% |
661,495
-59,230
| -8% | -$1.22M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.